Reviva Pharmaceuticals Inc. - Product Pipeline Review - 2013


Naperville, IL -- (SBWire) -- 10/08/2013 --Reportstack, provider of premium market research reports announces the addition of Reviva Pharmaceuticals Inc. - Product Pipeline Review - 2013 market report to its offering
Reviva Pharmaceuticals Inc. - Product Pipeline Review - 2013


Global Market Directs pharmaceuticals report, Reviva Pharmaceuticals Inc. - Product Pipeline Review - 2013 provides data on the Reviva Pharmaceuticals Inc.s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from proprietary databases, Reviva Pharmaceuticals Inc.s corporate website, SEC filings, investor presentations and featured press releases, both from Reviva Pharmaceuticals Inc. and industry-specific third party sources, put together by team.


- Reviva Pharmaceuticals Inc. - Brief Reviva Pharmaceuticals Inc. overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Reviva Pharmaceuticals Inc. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Reviva Pharmaceuticals Inc. with complete description of the products developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Reviva Pharmaceuticals Inc.s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate Reviva Pharmaceuticals Inc.s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Reviva Pharmaceuticals Inc. in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Reviva Pharmaceuticals Inc.s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Reviva Pharmaceuticals Inc..
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Reviva Pharmaceuticals Inc. and identify potential opportunities in those areas.

To view the table of contents for this market research report please visit
Roger Campbell
United States
Ph: 888-789-6604

Media Relations Contact

Roger Campbell
Director of Marketing

View this press release online at: